Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $54,657 - $60,638
-234 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $5,769 - $6,723
26 Added 12.5%
234 $58,000
Q4 2020

Mar 24, 2021

SELL
$216.38 - $257.67 $2,812 - $3,349
-13 Reduced 5.88%
208 $47,000
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $47,819 - $56,945
221 New
221 $50,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.